ITRM
Price
$0.77
Change
+$0.01 (+1.32%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
34.15M
30 days until earnings call
RNAZ
Price
$14.71
Change
+$2.49 (+20.38%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
12.34M
Interact to see
Advertisement

ITRM vs RNAZ

Header iconITRM vs RNAZ Comparison
Open Charts ITRM vs RNAZBanner chart's image
Iterum Therapeutics
Price$0.77
Change+$0.01 (+1.32%)
Volume$11.48K
Capitalization34.15M
TransCode Therapeutics
Price$14.71
Change+$2.49 (+20.38%)
Volume$6.32K
Capitalization12.34M
ITRM vs RNAZ Comparison Chart in %
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITRM vs. RNAZ commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITRM is a StrongBuy and RNAZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (ITRM: $0.76 vs. RNAZ: $14.80)
Brand notoriety: ITRM and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITRM: 112% vs. RNAZ: 4305%
Market capitalization -- ITRM: $34.15M vs. RNAZ: $12.34M
ITRM [@Biotechnology] is valued at $34.15M. RNAZ’s [@Biotechnology] market capitalization is $12.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITRM’s FA Score shows that 1 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • ITRM’s FA Score: 1 green, 4 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both ITRM and RNAZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITRM’s TA Score shows that 7 TA indicator(s) are bullish while RNAZ’s TA Score has 5 bullish TA indicator(s).

  • ITRM’s TA Score: 7 bullish, 2 bearish.
  • RNAZ’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than RNAZ.

Price Growth

ITRM (@Biotechnology) experienced а +14.32% price change this week, while RNAZ (@Biotechnology) price change was +39.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

ITRM is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITRM($34.2M) has a higher market cap than RNAZ($12.3M). ITRM YTD gains are higher at: -56.791 vs. RNAZ (-84.315). ITRM has higher annual earnings (EBITDA): -20.51M vs. RNAZ (-24.27M). ITRM has more cash in the bank: 13M vs. RNAZ (7.38M). RNAZ has less debt than ITRM: RNAZ (0) vs ITRM (32.6M). ITRM (0) and RNAZ (0) have equivalent revenues.
ITRMRNAZITRM / RNAZ
Capitalization34.2M12.3M278%
EBITDA-20.51M-24.27M85%
Gain YTD-56.791-84.31567%
P/E RatioN/A0.00-
Revenue00-
Total Cash13M7.38M176%
Total Debt32.6M0-
FUNDAMENTALS RATINGS
ITRM: Fundamental Ratings
ITRM
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITRMRNAZ
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LII554.5812.55
+2.32%
Lennox International
MMLP3.170.06
+2.06%
Martin Midstream Partners LP
STNG54.10-0.23
-0.42%
Scorpio Tankers
MSIF13.05-0.29
-2.17%
MSC Income Fund Inc.
MITQ0.95-0.03
-3.16%
Moving iMage Technologies

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
+0.63%
PLRX - ITRM
42%
Loosely correlated
+3.38%
ACRS - ITRM
34%
Loosely correlated
+3.26%
ORMP - ITRM
34%
Loosely correlated
-3.63%
TARA - ITRM
32%
Poorly correlated
+5.19%
RNAZ - ITRM
30%
Poorly correlated
+21.11%
More